Additional analyses (for probes not statistically significant for CRC risk) identified three more regions (POU6F1 in chromosome 12, GREM1 in chromosome 15 and STARD3 in chromosome 17) with evidence of a shared variant influencing both DNA methylation and CRC risk. This evidence concerns the gene GREM1 and colorectal carcinoma.